Navigation Links
Global Med Technologies(R) Licenses 90th Site in the Southeastern U.S.

Laurens County Automates Its Blood Bank

DENVER, March 31 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international healthcare information technology company, today announced that its Wyndgate Technologies(R) division has licensed its SafeTrace Tx(R) transfusion management system to Laurens County Health System of Clinton, South Carolina. Terms of the agreement were not disclosed.


Tina Strouse MCT(ASCP), Blood Bank Coordinator for Laurens County Health System, stated, "Our department was looking for an electronic system to manage our transfusion service. With the ISBT 128 labeling standard, our manual methods to track products were cumbersome at best. A managed system will be safer for our patients than hand generating the long ISBT label codes. SafeTrace Tx supports ISBT and will also allow us to track the products electronically and generate our reports much easier."

Ms. Strouse continued, "We were impressed by the features we were shown in the onsite demonstration. SafeTrace Tx looked easy to use and was able to interface with our laboratory information system. We felt that the system would allow us to transition easily from a paper environment to an electronic department."

SafeTrace Tx is transfusion management software which provides comprehensive tracking of orders, specimens, blood products, derivatives, and accessories with a complete testing and transfusion history in one consolidated record. These features will assist Laurens County Health System's blood bank in selecting suitable blood products for their patients, help to reduce waste, and increase efficiency in their blood bank.

Wm. Scott Dustin, Senior Vice President of Sales and Marketing for Global Med Technologies, commented, "We are very pleased to be working with Laurens County to implement our electronic hospital transfusion system. In today's financial environment, cost savings are vital to the survival of many organizations. Global Med companies are adding new products and continually improving our existing systems to help healthcare organizations perform more efficiently, reduce waste and improve their patient care. SafeTrace Tx has many features which assist organizations in accomplishing these goals."

About Laurens County Health Care System

Recognized as one of South Carolina's progressive community hospitals, Laurens County Health Care System is a state leader in providing innovative and informative educational programs in an effort to teach the community how to live healthfully and well. The state of the art hospital opened in 1990 and retains 450 employees, 60 volunteers, 48 board-certified physicians and 65 consulting physicians to serve its community of 72,000.

About Global Med Technologies(R), Inc.

Global Med Technologies, Inc. is an international healthcare information technology company which develops regulated and non-regulated products and services for the healthcare industry. As a leading provider of blood and laboratory systems and services, Global Med's products are deployed in 20 countries and serve over 2,100 transfusion centers, blood banks and laboratory sites.

Global Med's domestic companies are Wyndgate Technologies(R), a leader in software products and services for donor centers and hospital transfusion services; eDonor(R), which offers web-based donor relationship management systems; and PeopleMed(TM), Inc., which implements cost-effective software validation, consulting and compliance solutions to hospitals and donor centers.

Global Med's European subsidiary, Inlog, SA, is a leading developer of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally.

For more information about Global Med's products and services, please call 800-996-3428 or visit

This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.

SOURCE Global Med Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBays Novel Aganocide Drugs for Major Dermatological Conditions
2. Forward-Thinking Patient Recruitment Company Poised to Create Bridges Between Japanese Clinical R&D Industry and Global Clinical Trial Marketplace
3. 3rd Global Jatrophaworld Training 2009... Set to Create and Build a Sustainable non-food Biodiesel Industry
4. PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009
5. Increasing Economic and Business Risks Will Transform the Global Life Sciences Industry
6. Schering-Plough to Webcast Presentation at Barclays Capital Global Healthcare Conference
7. BioMed Realty Trust to Present at Citi 2009 Global Property CEO Conference
8. News Release: Homeland Security to Take Centre Stage with Global Security Asia 2009
9. Abbott to Present at Barclays Global Healthcare Conference
10. Frost & Sullivan Forecasts Early Rebound: Strong Growth Ahead for Global Economy
11. Global Biopharmaceutical Leader in Peptide Research Expands Commitment in San Diego/U.S. With New R&D Facility and Ready-To-Market Prostate Cancer Treatment Degarelix
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 2 ... première fois les différences entre les souches bactériennes ... celles des êtres humains . Ces recherches ... et envisager la prise en charge efficace de ... diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... QUEBEC CITY , Nov. 25, 2015 /PRNewswire/ ... "Company"), affirms that its business and prospects remain ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB ... program to completion following review of the final ... met Phase 2 Primary Endpoint in men with ...
(Date:11/25/2015)... San Francisco, CA (PRWEB) , ... November 25, ... ... leading microbial genomics company uBiome, were featured on AngelList early in their initial ... by launching an AngelList syndicate for individuals looking to make early stage investments ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), ... broader entry into the automotive market with a comprehensive ... pace of consumer electronics human interface innovation. Synaptics, industry-leading ... for the automotive industry and will be implemented in ... Europe , Japan , and ...
(Date:10/29/2015)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that it has been ... one of only three finalists for a 2015 ... Growing" category. The Tekne Awards honor Minnesota ... innovation and leadership. iMedNet™ eClinical ...
Breaking Biology News(10 mins):